TY - JOUR
T1 - Uses and Limitations of Portal Vein Embolization for Improving Perioperative Outcomes in Hepatocellular Carcinoma
AU - Truty, Mark J.
AU - Vauthey, Jean Nicolas
PY - 2010/4
Y1 - 2010/4
N2 - Hepatic resection remains the only curative option for the majority of patients with hepatocellular carcinoma (HCC) who do not meet criteria for transplantation or local ablative options. As the majority of patients with HCC also have underlying chronic liver disease and cirrhosis, post-hepatectomy complications can be significant, and in some prohibitive. The technique of portal vein embolization (PVE) has evolved to increase the candidacy of patients for major hepatectomy, as well as improve postoperative outcomes and safety. This review will focus on PVE and discuss our institution's experience with uses and limitations of this technique for HCC.
AB - Hepatic resection remains the only curative option for the majority of patients with hepatocellular carcinoma (HCC) who do not meet criteria for transplantation or local ablative options. As the majority of patients with HCC also have underlying chronic liver disease and cirrhosis, post-hepatectomy complications can be significant, and in some prohibitive. The technique of portal vein embolization (PVE) has evolved to increase the candidacy of patients for major hepatectomy, as well as improve postoperative outcomes and safety. This review will focus on PVE and discuss our institution's experience with uses and limitations of this technique for HCC.
UR - http://www.scopus.com/inward/record.url?scp=77952416423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952416423&partnerID=8YFLogxK
U2 - 10.1053/j.seminoncol.2010.03.013
DO - 10.1053/j.seminoncol.2010.03.013
M3 - Article
C2 - 20494702
AN - SCOPUS:77952416423
SN - 0093-7754
VL - 37
SP - 102
EP - 109
JO - Seminars in oncology
JF - Seminars in oncology
IS - 2
ER -